✦ LIBER ✦

Cerivastatin, a new synthetic HMG CO-A reductase inhibitor in the treatment of patients with primary hyperlipidaemia

✍ Scribed by V.V. Kukharchuk; E.Yu. Solovieva; T.A. Rozhkova; M.G. Tvorogova

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A long-term comparative trial of cerivas

✍ Jun Sasaki; Kikuo Arakawa; Kyosuke Yamamoto; Shozo Kobori; Masato Ageta; Suminor 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Effects of cerivastatin sodium, a new HM

✍ Susumu Tazuma; Gunji Yamashita; Hidenori Ochi; Hiroyuki Miura; Tsuyoshi Kajihara 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Pharmacodynamics of new HMG-CoA reductas

✍ A.G Olsson; J.S Pears; J McKellar; R.J Caplan; A Raza 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB

101 Cerivastatin—a new HMG-CoA reductase

✍ H. Dietrich; W. Ritter; W. Wingender; S. Unger; K. Ochmann 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB

F144 Long-term effect of a HMG-CoA reduc

✍ Hung-Hsiang Liou; Mei-Chyn Liu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Long-term treatment with pitavastatin (N

✍ Yoshihiro Noji; Toshinori Higashikata; Akihiro Inazu; Atsushi Nohara; Kosei Ueda 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB